Hindman Andrew A. 4
4 · Theravance Biopharma, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Award
Ordinary Shares
2021-02-08+65,000→ 188,688 total
Footnotes (1)
- [F1]Includes 553 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 13, 2020.